Evidence map›Paper›PMID 42358952›Full record

ReviewFrontiers in immunology2026

Allergenicity assessment of novel foods - lessons from immune endotyping of food-allergic patients.

Isabela Assugeni, Melike Gezen, Gül Duman, Naphisabet Wanniang, Françoise Codreanu-Morel, Gabriele Gadermaier, Theresa-Maria Boehm, Annette Kuehn

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Isabela AssugeniDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Melike GezenDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Gül DumanDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Naphisabet WanniangDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Françoise Codreanu-MorelDepartment of Allergology and Immunology, Centre Hospitalier de Luxembourg-Kanner Klinik, Luxembourg, Luxembourg.
Gabriele GadermaierDepartment of Biosciences and Medical Biology, Paris Lodron University Salzburg, Salzburg, Austria.
Theresa-Maria BoehmDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Annette KuehnDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel foods (NF), defined as foods not commonly consumed in Europe before May 1997, represent a growing area of interest in the pursuit of sustainable and nutritionally valuable diets. Before introduction to the market, however, their safety needs to be clearly demonstrated. Food allergy (FA) represents a significant public health burden and may also extend to NF. Regarding FA risk, the current guidelines for NF safety assessment address possible cross-reactivity with known allergens but offer little direction when allergenic potential is unknown. Conventional approaches such as specific IgE testing, often fail to predict clinically relevant immune responses in humans.

Indexed as

AllergensFoodFood HypersensitivityAnimalsHumansImmunoglobulin EAllergensImmunoglobulin Eallergenicity assessmentex vivo assaysfood allergynovel foodpatient endotypingrisk assessment

Identifiers

PMID42358952
PMCPMC13290677

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.